article thumbnail

Atrial arrhythmia and heart failure in congenital heart disease: a pas de deux with consequences

Heart BMJ

In adults with congenital heart disease (ACHD patients), atrial arrhythmias (AA) and heart failure (HF) are common. 1 Factors related to congenital heart disease, such as underlying anatomy, surgical repair technique and scars, can all be considered as AA substrates.

article thumbnail

Atrial arrhythmia and heart failure in adult patients with congenital heart disease: a retrospective cohort study

Heart BMJ

Background Atrial arrhythmias (AA) and heart failure (HF) are major causes of hospitalisation in adult congenital heart disease (ACHD). Methods In this single-centre retrospective cohort study, data from 3995 patients with ACHD were analysed.

article thumbnail

New therapeutic target for cardiac arrhythmias emerges

Science Daily - Heart Disease

Researchers identified a lipid that is involved in regulating cardiac ion channels, providing insights into possible mechanisms of cardiac arrhythmias in heart failure and a potential pathway for future therapeutic development.

article thumbnail

Gene-related metabolic dysfunction may be driving heart arrhythmia

Science Daily - Heart Disease

Patients with a common heart arrhythmia called Atrial Fibrillation could benefit from future treatments that target inefficiencies in heart cell metabolism, according to a new article.

article thumbnail

Predicting cardiac arrhythmia 30 minutes before it happens

Science Daily - Heart Disease

Atrial fibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. This irregular heartbeat is associated with increased risks of heart failure, dementia and stroke. It constitutes a significant burden to healthcare systems, making its early detection and treatment a major goal.

article thumbnail

Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

Random-effects meta-analyses examined the pooled risk difference in the prevalence of each symptom or symptom combination in cases with confirmed SARS-coV-2 infection compared with controls.ResultsEight cohort studies were eligible, including nearly 10 million people.

article thumbnail

Injectable hydrogel electrodes open door to a novel painless treatment regimen for arrhythmia

Science Daily - Heart Disease

Biomedical engineers set the foundation for a ground-breaking treatment regimen for treating ventricular arrhythmia. The scientific advance is significant considering pain management is highly relevant to overall wellness for patients with heart, lung, and blood diseases.